Abstract
In this issue of Advances, section editors Oksana Shlobin, MD, and Jonathan Rich, MD, review findings from 2 recently published studies focused on outcomes and implications of the REVEAL registry. Farber HW, Miller DP, Poms AD, et al. Five-year Outcomes of Patients Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension (PAH) Disease Management (REVEAL). Chest. 2015 Jun 11. [Epub ahead of print] Benza RL, Miller DP, Foreman AJ, et al. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease (REVEAL) analysis. J Heart Lung Transplant. 2015;34(3):356–361.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
